For instance, the TGF-β signaling pathway was found to be altered through glioma progression, as observed by an increase in the level of BMP molecules, including BMP3 and BMP4, as well as their targets, such as Smad1/5/8 and Id. This evidence concerns the gene SMAD1 and central nervous system cancer.